Topics:

Diabetes

Type 2 Diabetes and Medication Adherence: Where is the Disconnect?

Incretin drugs, which offer ease of use, very little hypoglycemia, and no weight gain (or even weight loss) seem to be an ideal therapy. But 80% to 90% of patients don’t stay on them. Why not?

Diabetes

Survivors of Hodgkin lymphoma may be at increased risk of diabetes if they were exposed to radiation to the para-aortic lymph nodes and spleen during treatment.

Use these 5 brief summaries of recent developments in the study of diabetes and trends in diabetes care to stay current and optimize care for your patients.

If the BCGS model is accurate, brain and periphery communicate continuously about glucose homeostasis and a change in the brain can alter insulin sensitivity in the periphery. Read this review, and you'll be up-to-date.

Studies looking at add-on treatment with SGLT2 inhibitors show their effects on glycemic control to be roughly additive. Here, a concise look at clinical trial results plus guidance on renal dose adjustment.

For the 30% of people with T2DM who are unable to achieve target A1C values through intensification of injected insulin therapy, a new study suggests the answer may be "yes."

discoid lupus erythematosus

Discoid lupus erythematosus; pharmacologic options for “statin-intolerant” patients; treatment of diabetic peripheral neuropathic pain . . . questions on these and other topics in this quiz.

Online support groups, YouTube videos on injection technique, healthy lifestyle sites--good patient information abounds on the Web. But so do the bad and the ugly. I try to help my patients discriminate; I'm not always successful.

Pages

Subscribe to Diabetes on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.